Proteins that bind DNA or RNA are often considered and studied independently of one another. For example, transcription factors are usually modelled relatively simply: they bind to genomic promoters and control target gene expression by activating or repressing RNA polymerases. Following transcription, RNA-binding proteins modulate protein expression by regulating the stability and translation of mRNAs. However, the consideration of DNA-and RNA-binding functions within proteins as separate entities is becoming outdated. The unappreciated dual DNA-and RNA-binding capacity of a growing body of proteins plays a key part in modulating gene expression, cell survival and homeostasis. Recent studies have demonstrated that many transcription factors are capable of binding diverse types of RNA, which enables them to bind to the mRNA products of transcription to regulate their turnover and to integrate other signals, such as responses to stress [1] [2] [3] [4] [5] [6] [7] . Additionally, the prevalence and emerging functions of long non-coding RNAs (lncRNAs) have revealed that non-codin g RNAs target many types of proteins through direct interactions 1, [8] [9] [10] [11] . In this Analysis, we enumerate these DNA-and RNA-binding proteins (DRBPs) and describe their functions, structures and evolution. We first broadly discuss the prevalence of DRBPs within the human genome. We highlight known functions of DRBPs with specific examples of how the simultaneous and serial RNA and DNA interaction allows better gene targeting, finer control of gene expression and integration of meta bolic state or stress to modulate protein activity. We discuss the structural features of DRBPs that enable dual nucleic acid specificity, focusing on the limited number of solved structures that allow direct comparison of a DRBP complexed with either DNA or RNA. Finally, we discuss the evolution of dual DNA-and RNA-binding domains within DRBPs, including ancient domains, for which dual DNA and RNA binding conferred a selective advantage, and more modern domains, which have recently been targeted by rapidly evolving lncRNAs.
Defining DRBPs
Defining the subset of human proteins that bind both DNA and RNA is a difficult task. Using gene ontolog y searches, only 64 human protein-coding genes in the QuickGO gene ontology database 12 (European Bioinformatics Institute) are identified as having direct and specific experimental evidence for both RNA bindin g (GO:0003723) and DNA binding (GO:0003677) (FIG. 1a) . The PROTEOME database (BioBase) returns 122 such proteins, although direct evidence is lacking for many of them.
An alternative approach involves combining evidence from studies that have separately attempted to catalogue all human proteins that bind DNA or RNA (FIG. 1b) . A study using protein microarrays and bio informatic approaches identified >4,000 human proteins that directly interact with double-stranded DNA (dsDNA) in vitro Nature Reviews | Molecular Cell Biology Another study used a crosslinking-and mass spectrometry-based approach to identify 860 mRNAbinding proteins from HeLa cells termed the mRNA interactome 14 . Functional analysis of these proteins again indicates that dual nucleic acid binding is a widespread phenomenon (FIG. 1d) , as they are significantly enriched for both ssDNA binding and dsDNA binding (P = 8.9 × 10 −21 and P = 5.5 × 10 −8
, respectively). Notably, of the 860 proteins identified as mRNA binding, 407 (47.3%) were independently characterized as dsDNA binding in REF. 2 . Together, the two studies indicate that DRBPs are widespread, perhaps constituting 2% of the human proteome (407 of ~20,300 proteins, FIG. 1b) . This number would probably increase if the studies included proteins that are expressed in other cell types, proteins that require ligand binding-dependent signals for nucleic acid binding, or proteins that bind other types of DNA or RNA.
We note that many of the proteins identified in REFS 13,14 as DNA and/or RNA binding lack corroborating evidence from other studies, and these findings should thus be interpreted with caution. For example, many identified proteins, such as polymerase sub units, may bind nucleic acid-bound proteins without binding DNA and/or RNA directly. Additionally, many proteins that bind DNA or RNA in vitro may not bind them in vivo. However, the two studies provide a reasonable estimate of potential human DRBPs owing to their wide coverage of the human proteome, and we discuss below examples in which the demonstration of protein-nucleic acid binding in vitro has preceded the discovery of such binding in vivo, sometimes by decades.
In Supplementary information S1 (table) , we provide a detailed list of 149 human DRBPs, with comments on their nucleic acid-binding properties, structures and functions. These proteins were selected based . There are 407 proteins found in both studies, indicating that they may bind both mRNA and dsDNA. In parts a and b, circles are drawn to scale. c | Molecular function gene ontology analysis reveals that RNA binding is a potentially major function of the dsDNA-binding proteins identified in REF. 13 . d | Gene ontology analysis reveals that DNA binding is potentially a major function of the mRNA-binding proteins identified in REF. 14. In parts c and d, only selected molecular function attributes are shown for brevity. P values in parts c and d indicate the probability that the over-representation of the stated ontology term in the selected 407 genes compared with all human genes is due to chance. These were calculated in the TRANSFAC + PROTEOME database (BioBase) using the hypergeometric distribution; "very large" indicates a P value of <1 × 10 −40 (-log(P) >40). rDNA, ribosomal DNA; ssDNA, single-stranded DNA. on experimental evidence demonstrating their ability to bind directly to both DNA and RNA, generally obtained from studies using more traditional experimental approaches than the high-throughput studie s 13, 14 discussed above. Although many of the proteins in Supplementary information S1 (table) have only been shown to bind DNA and/or RNA in vitro, the remainder of this Analysis focuses on selected human DRBPs with known cellular roles.
Functions of DRBPs
We carried out gene ontology and domain enrichment analyses (FIG. 2) to illuminate the main biological functions of our list of human DRBPs (see Supplementary information S1 (table) ). The gene ontology analysis revealed expected biological processes, such as transcriptional regulation, mRNA processing and DNA replication. However, several surprising functions are also implicated, including the DNA-damage response, apoptosis and responses to extreme temperatures (FIG. 2a) . Ultimately, DRBP functions are governed by their inherent structural and biochemical properties. One can envision DRBPs capitalizing on both RNA and DNA binding in numerous ways; for example, a transcription factor that binds DNA and RNA may interact orthogonally with RNAs that compete with DNA binding to repress transcription, or simultaneously with a promoter and an RNA co-activator to upregulate transcription. The following section focuses on DRBPs that bind DNA and RNA competitively (FIG. 3a) .
Binding DNA or decoy RNAs. The role of certain lncRNAs as decoys of genomic DNA is illustrated by the reduction in promoter occupancy by transcription factors, typically measured by chromatin immunoprecipitation (ChIP), in response to the overexpression of competing decoy RNAs. The glucocorticoid receptor (GCR), a steroid hormone receptor, is a classic example of a ligand-activated transcription factor (reviewed in REF. 15 ). In its inactivated state, the GCR is kept in the cytoplasm by chaperone proteins. Upon ligand binding, the GCR translocates to the nucleus, where it can bind to the promoters, and regulate the transcription, of hundreds of genes 16 . Given the antiinflammatory role of the GCR, much effort has been put into developing modulators of GCR-driven transcription 17 . Recently, the lncRNA growth arrest-specifi c 5 (GAS5) was found to inhibit the transcriptional activity of the GCR by competing directly with DNA for protein binding in vitro and in cells 1 ; overexpression of GAS5 leads to a decrease in ChIP-detected GCR occupancy at its target promoters, as well as a decrease in the mRNA levels of glucocorticoid-activated genes 1, 18 . As cellular GAS5 levels are regulated by nonsense-mediate d decay 18 in response to serum starvation and other stressors 1 , the transcriptional activity of the GCR is tuned by titrating the levels of GAS5 against the fixed number of genomic GCR-binding sites in response to cellular stress. Three closely related steroid receptors that share the DNA specificity of the GCR -the androgen, progesterone and mineralocorticoid receptors -are also susceptible to GAS5-mediated transcriptional repression 1 . Although steroid receptors have traditionally been thought of as DNA-binding proteins, the affinity of the GCR for RNA and DNA is similar, as measured in vitro by glutathione S-transferase pulldown assays and fluorescence-based competition assays 1 . The most distantly related member of the steroid receptor family, the oestrogen receptor, does not share the DNA specificity of the GCR and is not susceptible to GAS5-mediated transcriptional repression, indicating that the binding of steroid receptors to RNA is sequence specific 1 . (table) ) were subjected to gene ontology enrichment of biological process (PROTEOME database; BioBase) and to INTERPRO domain enrichment (DAVID ontology 77, 78 ) in order to explore the biological functions of and protein domains commonly found in DRBPs. a | In gene ontology analysis, biological processes such as transcriptional regulation and mRNA processing are expectedly prominent terms found to be enriched in DRBPs. However, unexpected functions are also enriched, including response to many cellular stresses (such as heat, viral infection and radiation). Additional examples of pairs of transcription factors and decoy RNAs are nuclear factor-Y (NF-Y), which binds the lncRNA P21-associated ncRNA DNA-damage activated (PANDA) 8 , and NF-κB, which binds the mouse pseudogene-derived RNA Lethe
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. The dual nucleic acidbinding activity of NF-κB was demonstrated in vitro many years before the discovery of an endogenous RNA target 10 , suggesting that transcription factors that are known DRBPs in vitro may have endogenous RNA targets awaiting discovery; an example of such DRBPs is the acute myeloid leukaemia 1 (AML1; also known as RUNX1) protein 19 . Although structural information on the interaction of human proteins with their decoy RNAs is lacking, a recent study demonstrated an elaborate mechanism of an analogous bacterial system: the sequestration of ribosomal RNA small subunit methyltransferase E (RsmE) by the non-coding RNA RsmZ 11 . Competitive DNA and RNA binding is a feature not only of transcription factors but also of nucleic acid-modifying enzymes, such as DNA methyltransferases. In humans, DNA methylation is initiated by DNA (cytosine-5)-methyl transferase 3A (DNMT3A) and DNMT3B; DNMT1 maintains this methylation by binding to hemimethylated DNA after replication (reviewed in REF. 20 ). RNA binding can inhibit the DNA-binding and methylation activity of both DNMT3A 21 and DNMT1 (REF. 22 ). In vitro, DNMT1 binds RNA with a higher affinity than DNA, as shown in electrophoretic mobility shift assays (EMSA) 21 . In the case of DNMT1, and probably in that of DNMT3A, RNAs bind to the catalytic domain of the methyltransferase to inhibit DNA methylation 21, 22 . It is notable that several metabolic enzymes -such as the glycolytic enzymes lactate dehydro genase [23] [24] [25] , glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [26] [27] [28] and α-enolase (ENO1) 14, 29, 30 -are DRBPs with competitive DNA-and RNA-binding capacities. In the case of GAPDH, DNA and RNA compete for binding of the cofactor NAD + to the enzyme 26, 28 , suggesting that Rossmann fold-containing proteins such as GAPDH may be sensitive to cellular DNA and/or RNA levels. ENO1 binds RNA as a monomer 30 , which inhibits the formation of the catalytically active protein dimer 31, 32 . NAD + -specific isocitrate dehydrogenase, which converts isocitrate to α-ketoglutarate, is allosterically inhibited by the 5ʹ untranslated regions of yeast mitochondrial mRNA 33 . Binding of RNA and DNA to metabolic enzymes indicates that nucleic acids can regulate the function of proteins other than transcription factors to modulate cellular metabolism 34 .
DRBPs that regulate gene expression at multiple level s.
Approximately half of the DRBPs we identified in our analysis are transcription factors. As discussed above, some such proteins have been shown to be the targets of decoy RNAs. By contrast, several others bind both the DNA and the mRNA of their target genes (FIG. 3b) .
Regulating genes at both the DNA and the RNA levels allows powerful, combinatorial control over protein expression and may enable DRBPs to generate both immediate effects (through regulating RNA turnover) and long-lasting effects (through regulating transcription).
When activated, the GCR can promote the transcription of anti-inflammatory genes 35 and repress the transcription of pro-inflammatory genes 36, 37 . Agonist-bound GCR destabilizes the mRNA of pro-inflammatory genes such as the chemokine (C-C motif) ligand 2 (CCL2; also In addition to binding to the promoters of genes to regulate their transcription, DRBPs can also affect microRNA (miRNA) processing, as well as mRNA stability and translation. c | DRBPs can bind DNA and RNA simultaneously, allowing the RNA to function as a scaffold to recruit other proteins to a specific DNA locus. Shown here is steroidogenic factor 1 (SF1) binding to the long non-coding RNA (lncRNA) steroid receptor RNA activator (SRA) to recruit the SRC1 (also known as NCOA1) transcriptional complex in a ligand-independent manner. NF, nuclear factor; NF90, NF of activated T cells 90 kDa; pre-miRNA, precursor miRNA; pri-miRNA, primary miRNA.
Drosha
A nuclease of the RNase III family that, as part of a complex, cleaves primary microRNA (pri-miRNA) transcripts into precursor mi RNAs (pre-miRNAs) in the nucleus.
Primary miRNA
(Pri-miRNA). The primary transcripts of microRNAencoding genes, which are stem-loop structures processed by the Drosha complex into precursor mi RNAs (pre-mi RNAs). Typical pri-mi RNAs are hundreds of base pairs long and can contain several pre-mi RNAs.
Precursor miRNA (Pre-miRNA). The product of Drosha-mediated cleavage of primary microRNAs (pri-miRNAs). Stem-loopstructured pre-mi RNAs are exported to the cytoplasm and further processed by Dicer to fully mature mi RNAs.
MAD homology 1 domain
An evolutionarily conserved domain found in SMAD proteins. It contains four α-helices, six short β-strands and five loops, and it recognizes specific DNA sequences.
known as MCP1) gene through direct RNA binding, perhaps by the recruitment of ribonucleases 38 . The presence of a GCR-binding motif in many immunogenic mRNAs has been confirmed using RNA immunoprecipitation (RNA-IP) and suggests that the GCR can accelerate the decay of many mRNAs, broadening its known role in the anti-inflammatory reponse 2 . Given that the GCR also binds directly to pro-inflammatory transcription factors, such as adaptor protein complex 1 and NF-κB 39, 40 , it seems that the GCR uses its diverse DNA-, RNA-and protein-binding capacities to regulate inflammatory genes at the transcriptional and post-transcriptional level.
Transcription factors can also regulate gene expression post-transcriptionally through the regulation of microRNA (miRNA) biogenesis. mi RNAs are small RNAs that facilitate gene silencing through sequencespecific pairing to target mRNAs and recruitment of these to the RNA-induced silencing complex (RISC; reviewed in REF. 41 ). Several transcription factors have been shown to regulate Drosha-mediated primary miRNA (pri-miRNA) processing, a key step in the biogenesis of functional mi RNAs 42 . SMAD proteins, which are transducers of transforming growth factor-β (TGFβ) signalling, activate transcription by forming a DNA-binding hetero dimer (reviewed in REF. 43 ). SMAD proteins also increase the levels of several mi RNAs, including miR-21 (REF. 44 ), which has important roles in development and immunity 45 . Surprisingly, the increase in miR-21 levels is due not to increased transcription of pri-miR-21 but to increased Drosha-mediated processing of pri-miR-21 to the precursor miRNA (pre-miRNA) mir-21 (REF. 44 ). Bioinformatic analysis identified a conserved RNA motif in TGFβ-regulated mi RNAs, which was shown by RNA-IP and EMSA to bind directly to the MAD homolog y 1 domain of SMAD to mediate Drosha processing 3 . Interestingly, the RNA sequence motif that is bound by SMAD4 and that mediates the regulation of miRNA expression post-transcriptionally is identical to the DNA sequences that are bound by SMAD4 and that mediate regulation of gene expression transcriptionally 3 . NF of activated T cells 90 kDa (NF90; also known as ILF3) is a particularly versatile DRBP that, along with its partner NF45 (also known as ILF2), has important roles in T cell activation 46 . Through the direct binding of DNA, mRNA and miRNA, NF90 controls transcription 4, 5 , regulates mRNA turnover and translation 47, 48 , and affects miRNA processing 49 , respectively. These functions assist in its role in T cell activation: NF90 upregulates the mRNA levels of interleukin-2 (IL-2), a critical cytokine in T cell development 50 , by binding its promoter to activate its transcription and by stabilizing the IL-2 mRNA through direct binding to its 3ʹ untranslated region, as was found by EMSA and ribonucleoprotein (RNP) immunoprecipitation analysis 5, 48 . Additionally, using in vitro pri-miRNA-processing assays and RNA-IP, NF90 in complex with NF45 was shown to inhibit the processing of the pri-miRNA pri-let-7a by binding it directly 49 . let-7a represses IL-6, a cytokine that is critica l for T cell survival and proliferation 51 , which may link inflammation to cancer 52 , and let-7 downregulation following NF90 upregulation reduces survival in several cancer types 53, 54 . In summary, these examples illustrate that DRBPs can use both transcriptional and post-transcriptiona l mechanisms to serve as potent controller s of gene expression.
Simultaneous binding of DNA and RNA. In contrast to DRBPs that target DNA or RNA serially to serve different or related functions, another class of DRBPs binds RNA and DNA simultaneously to perform a single function (FIG. 3c) . Generally, transcription factors not only require DNA binding to target promoters but also bind to co-repressors or co-activators to affect transcriptional regulation. There are several examples of RNA molecules acting as co-activators by simultaneously binding DNA and various transcription factors. The lncRNA rhabdomyo sarcoma 2-associated transcript (RMST), in particular, is required for binding of neurogenic gene promoters and subsequent upregulation by SOX2 (REF. 55 ), a transcription factor with important roles in development, pluripotency and cell fate 56 . RNA-IP and RNA pulldown experiments showed that RMST interacts directly with SOX2 (REFS 55, 57) , and DNA occupancy of SOX2 measured by ChIP followed by sequencing (ChIPseq) was reduced following RMST depletion 55, 57 . The lncRNA EVF2 is a transcriptional co-activator of DLX2 (REF. 58 ) and recruits methyl-CpG-binding protein 2 (MECP2) to intergenic enhancers 59 . A direct interaction between DLX2 and EVF2 has been demonstrated by the immunoprecipitation of DLX2 followed by reverse transcription PCR of the EVF2 lncRNA 58 , and MECP2 also has previously been shown to bind RNA 60 . It should be noted that RNA-mediated recruitment of a protein to a particular DNA locus might not require direct binding of both DNA and RNA by the protein, as lncRNAs could recruit transcription factors to a particular DNA locus to which the lncRNA is bound. Dual nucleic acid recognition also facilitates targeted gene repression through RNA-guided DNA methylation. This phenomenon was first discovered in plants 61 , and some mammalian RNA guides of DNA methylation have since been found 62, 63 , although their mechanisms of action are less clear. In mice, DNMT3A forms a complex with Tsix RNA to promote methylation of the X-inactive-specific transcript (Xist) promoter 64 . Several nuclear receptors -including steroidogenic factor 1 (SF1), DAX1 (also known as NR0B1) and thyroid receptor-α (TRα) -bind simultaneously to both gene promoters 65, 66 and the RNA co-activator SRA (steroid receptor RNA activator) to modulate transcriptional activation 6, 7 (FIG. 3c) . Using pulldown experiments, SF1 and TRα have been shown to bind SRA through their hinges, which are flexible, disordered regions that connect their DNA-and ligand-binding domains 6, 67 . Knockdown of SRA decreases the interaction of SF1 with protein transcriptional activators and the transcription of SF1-regulated genes 6 . Several other nuclear receptors associate with, but lack direct evidence for direct binding to, SRA, including the androgen, progesterone and oestrogen receptors, as well as retinoic acid receptor-α (RARα), which may bind SRA and its target gene promoters simultaneously 7, [68] [69] [70] .
Homeodomain
A protein structural domain that binds DNA and RNA, and that is found most commonly in transcription factors. It consists of a helixturn-helix structure of 60 amino acids.
GAR domain
A Gly-and Arg-rich motif that adopts a repeated β-turn structure. It is found most commonly in proteins that bind RNA.
Zinc-finger domains
Structural motifs that are characterized by the coordination of one or more zinc ions. There are several different zinc-finger motifs, and each displays a different binding mode and structure.
WW domains
Small protein motifs of 40 amino acids that mediate specific protein-protein interactions with short Pro-rich or Pro-containing motifs.
Ftz-F1 domain
A protein domain first identified in the Fushi Tarazu factor 1 (FTZ-F1) nuclear receptor. It contains an evolutionarily conserved LXXLL motif that recognizes other LXXLL-related motifs.
K-homology domain
A conserved protein domain that interacts with both RNA and DNA through a binding cleft formed between two α-helices, two β-sheets and the GXXG loop.
Cold-shock domain Crosslinking immunoprecipitation has demonstrated that RARα can bind to and regulate the translation of target mRNAs through a unique RNA-binding motif at its carboxyl terminus 71 . Another example of simultaneous DNA and RNA binding that is required for DRBP function is the role of telomeric repeat-binding factor 2 (TRF2; also known as TERF2) at telomeres. Deletion of TRF2 leads to an arrest in cell division caused by the formation of chromosome end-fusions 72 . Crystal structures have revealed that TRF2 binds to telomeric DNA in a sequence-specific manner through a C-terminal DNA-binding domain, which resembles a homeodomain 73 . Part of the role of TRF2 at the telomere includes the recruitment, through its positively charged amino-terminal GAR domain, of the origin-recognition complex (ORC, which is a collection of proteins that serves as a scaffold for DNA replication factors, among other functions 74 ) so that it can assist in the maintenance of telomere structure 75 . Using biotinylated RNA pulldown experiments, RNA-IP and EMSAs, the GAR domain responsible for ORC recruitment was later shown to bind telomere repeat-encoding RNA (TERRA) 76 . Depletion of TERRA hampers ORC recruitment to the telomere without affecting TRF2 binding to the telomere itself, suggesting a model in which TRF2 serves as a mediator between telomere DNA and TERRA, which in turn recruits factors required for telomere maintenance 76 .
Structural characteristics of DRBPs
For a protein such as TRF2 to coordinate telomeric DNA binding and recruit protein complexes by binding of RNA, it must have multiple nucleic acid-binding motifs. Some DRBPs, such as the GCR and NF-κB, have maintained domains that are capable of binding both DNA and RNA, which allows decoy RNAs to evolve and compete with DNA for protein binding. We analyse below the prevalence of structural domains in DRBPs and discuss examples of DRBPs that bind both single-stranded and double-stranded nucleic acids.
DRBP domains that enable DNA and RNA interactions.
We carried out InterPro domain enrichment analysis by DAVID 77,78 on our 149 DRBPs to identify domains enriched in proteins that bind both DNA and RNA (FIG. 2b) . The RNA-recognition motif (RRM; also known as the RNP domain or RNA-binding domain) was the most highly enriched domain in DRBPs (P = 2 × 10 −26 ). The RRM is an abundant, short (~100-amino-acid long) domain that generally recognizes ssRNA and is often present in proteins with other domains, such as zinc-finger domains, WW domains or additional RRMs 79 . Such multidomain DRBPs may bind RNA and DNA simultaneously through separate domains, as occurs with heterogenous nuclear RNA A1, which contains two RRMs 80 . Single RRM-containing proteins are also capable of binding both DNA and RNA, and this function is present, for example, in RNA-binding motif 3 (RBM3), TBP-associated factor 15 (TAF15), and TAR DNA-binding protein 43 (TDP43; also known as TARDBP) [81] [82] [83] (see Supplementary information S1 (table) ). Such bivalent domains may not have the same sequence specificity when binding DNA and RNA, highlighting the complexity of recognizing nucleotide bases in a sequence-dependent manner.
Nuclear receptor domains are also enriched in DRBPs: RARα binds mRNA through a unique C-terminal domain 71 , SF1 binds the RNA co-activator SRA through its hinge and a unique Ftz-F1 domain, and TRα binds SRA through its hinge 6, 67 . The majority of nuclear receptors have two highly conserved Cys 4 zinc-fingers through which they bind DNA, and some nuclear receptors, such as the GCR, can also bind RNA through these domains 1 . Other types of zinc-fingers are also enriched in DRBPs, such as the RAN-binding protein 2 (RANBP2) type. Other notably enriched domains in DRBPs are the K-homology domain, the dsRNA-binding domain (dsRBD), the cold-shock domain (CSD) and various helicase domains. Each of these domains is capable of binding DNA and RNA, and we focus below on the structural mechanisms underlying this dual specificity.
General properties of DRBPs. There are only two chemical differences between RNA and DNA. First, RNA (but not DNA) has a 2ʹ hydroxyl (2ʹOH) group on the ribose sugar, which allows an additional hydrogen bond to be formed and a greater diversity of secondary structures than is possible in DNA. Second, RNA contains uracil rather than thymine, as in DNA; uracil lacks a methyl group at the C5 position. A comparative analysis of known protein-nucleic acid structures revealed that the recognition of DNA occurs largely through electrostatics and direct base-protein inter actions. Conversely, RNA recognition by proteins mainly depends on shape complementarity and interaction with the 2ʹOH group 81 . Given these general differences, one could expect that, during evolution, highly selective protein interfaces would be generated that are optimized for either RNA or DNA, with minimal cross-binding. However, the most energetically favourable associations between proteins and nucleic acids relay on hydrophobic and charge-charge interactions. These interactions are less constrained than interactions with the sugar backbone or with the nucleotide base edge, which is capable of highly-specific Watson-Crick base pairing. Thus, DRBP domains that competitively bind DNA and RNA probably rely on the less specific hydrophobic and charge-charge interactions. For example, ssRNA-binding proteins are more likely to form hydrogen bonds with bases rather than with the phosphatesugar backbone, compared to those that recognize folded RNA, such as ribosomal proteins and tRNA synthetases 82 . Because ssRNA-binding proteins do not rely heavily on sugar recognition, they are more likely to also bind DNA. This may explain why the RRM is the most enriched domain in the DRBPs included in our analysis 82 (FIG. 2b) .
The RRM. The RRM is an extremely versatile domain that is capable of binding (mainly single-stranded) RNA and DNA, as well as proteins 79 . RRMs preferentially interac t with nucleic acid bases rather than with the phosphate-sugar backbone. The structural nature of ssRNA and ssDNA allows much easier access to the exposed aromatic base faces, as opposed to hydrogen bonding to the base edges that occur frequently with double-stranded nucleic acid-binding DRBPs. Additionally, stacking interactions with the faces of bases are more energetically favourable than recognition of the nucleotide edge. Therefore, stacking inter actions between aromatic protein side chains and nucleic acid bases are often observed in single-stranded nucleic acid-binding proteins. TDP43 is a DRBP that has important roles in mRNA splicing and miRNA biogenesis 83, 84 . It contains two RRMs, which are separated by a short loop and are both capable of binding DNA and RNA. Crystal structures of the TDP43 RRMs in complex with DNA and RNA have been reported 85, 86 (see also the currently unpublished structure of TDP43 RRMs), making TDP43 an excellent case study for dual DNA and RNA recognition by RRMs. The DNA-and RNA-bound structures of TDP43 reveal nearly identical modes of nucleic acid recognition. Aromatic side chains, such as Phe149 within the first RRM (RRM1), form stacking interactions with DNA or RNA bases (FIG. 4a) . Trp113, which is part of the more flexible loop 1, is able to shift conformations and basestack slightly differently when bound to different nucleic acid sequences (FIG. 4b) , whereas Phe149 in the rigid β 3 sheet of the RRM1 fold makes similar interactions with DNA and RNA (FIG. 4a) . Relying on the more energetically favourable π-stacking interactions through the planar face of the DNA and RNA bases results in less specificity than that gained from hydrogen bonding with the base edge. Uracil and thymine interact with Phe194 of the second RRM (RRM2) in the RNA-and DNA-bound structures, respectively (FIG. 4c,d ). Despite the additional methyl moiety at position C5 in the DNA, no TDP43 residues recognize the edge of the nucleotide to interact or clash with the additional carbon (FIG. 4d) . Thus, one of the chemical differences between DNA and RNA, the use of uracil in RNA, plays no part in nucleic acid discriminatio n in this example.
By contrast, the RRM2 of TDP43 does make RNAspecific contacts with the 2ʹOH group. The majority of protein-2ʹOH group interactions are mediated through protein side chains 81 , and both the Lys263 and Arg227 (FIG. 4e) side chains in RRM2 contact a 2ʹOH group when bound to RNA. However, when TDP43 is bound to DNA, these same protein side chains contact the DNA backbone phosphates (FIG. 4f) , demonstrating that amino acids are capable of reorienting to allow distinct types of interactions to support RNA and DNA binding. Nevertheless, DNA binding is not a general property of all RRMs. For example, the RRM of poly(A)-binding protein relies on many RNA-specific 2ʹOH contacts for RNA interaction, and binding to DNA may be at low affinity, if detectable at all 87 . part d) ; the additional methyl group at C5 in thymine does not contribute to nucleic acid specificity. e | When bound to RNA, both the terminal amine and ε-nitrogen of Arg227 in RRM2 of TDP43 contact a 2ʹ hydroxyl (2ʹOH) group on the RNA backbone. f | By contrast, these same groups can also make contacts with the DNA backbone, both directly and through water-mediated hydrogen bonding. g,h | The p50 subunit of nuclear factor-κB (NF-κB) makes strikingly similar base-specific contacts when bound to an RNA aptamer (part g) or to double-stranded DNA (part h). This is due in large part to the similar secondary structure and chemical moieties presented by the RNA and DNA. Major groove width was calculated with 3DNA software using phosphate-phosphate distances 92 .
Aptamers
Single-stranded DNA or RNA molecules that selectively bind small molecules, proteins and peptides with high affinity. Aptamers have dynamic tertiary structures, which contribute to the diversity of their binding targets.
Z-DNA
DNA in the conformation of a left-handed double helix.
Z-RNA
RNA in the conformation of a left-handed double helix.
Y box
A DNA target sequence with the consensus CTGATTG, which is recognized and bound by certain proteins.
RNA homopolymers
Sequences of ribonucleotides consisting of a single base; for example, CCCCCCCCC.
DRBPs that recognize double-stranded nucleic acids.
Crystal structures of protein-dsRNA complexes are less common than their single-stranded counterparts, but there are some examples that are instructive for dual nucleic acid recognition. NF-κB is a central transcription factor of immune signalling and is formed of homodimers or heterodimers of Rel family proteins, such as p50 (also known as NFKB1) or p65 (also known as RELA) 88 . High-affinity aptamers have been developed for both the p50 subunit and the p65 subunit of NF-κB, with an affinity of RNA binding that approaches that of the transcription factor's affinity for native DNA response elements 10, 89 . DNA with an identical sequence to the p50-targeting aptamer will not bind p50 (REF. 10); p50 is therefore another DRBP that binds RNA and DNA in a sequence-specific manner, with different sequence specificitie s for each.
Crystal structures of p50 bound to DNA and to RNA reveal that both bind at the same surface of the p50 immunoglobulin-like domain 90, 91 . Although p50 binds to RNA as a monomer and to DNA as a dimer, similar networks of base-specific interactions occur between protein and nucleic acids in each structure (FIG. 4g,h ). Not only do the DNA-and RNA-contacting residues of p50 maintain an equivalent position, but both DNA and RNA also present similar interfaces for p50 recognition in charge distribution and in secondary structure 92 ( FIG. 4g,h ). This is a seminal, structurally confirmed example of 'DNA mimicry' by RNA to bind to a transcription factor and, although the RNA in this case was artificial, DNA mimicry has been hypothesized to play a part in the endogenous regulation of several transcription factors 1, 93 . Structures have also been solved of the DRBP dsRNAspecific adenosine deaminase 1 (ADAR1), which binds both double-stranded Z-DNA and double-stranded Z-RNA through its unique Zα domain 94, 95 . The ability of the Zα domain to make sequence-independent interactions with the Z-form phosphate backbone of both DNA and RNA enables ADAR1 to sense nucleic acid secondary structure conformations. Thus, double-stranded nucleotidebindin g DRBPs can recognize their DNA and RNA targets through sequence-specific interactions (in the case of NF-κB) or through nonspecific interactions with the DNA and RNA backbone (in the case of ADAR1).
The evolution of DRBPs
The evolutionary forces driving the structure and function of DRBPs are complex, but understanding them will help us to identify new DRBPs and perhaps predict their susceptibility to interactions with lncRNAs. Although the DRBPs identified in our analysis are members of many different structural classes, each with their own evolutionary history, we focus on members of two very dissimilar DRBP families: CSD-containing proteins and eukaryotic DNA methyltransferases. CSD-containing proteins, which are required to protect cells from low temperatures, are members of an ancient DRBP family that uses weak selection criteria to interact with nucleic acids and therefore intrinsically bind to both DNA and RNA. Members of the eukaryotic DNA methyltransferase family are DRBPs that have more recently evolved the ability to recognize both DNA and RNA: they preferentially interact with DNA, and only one family member (DNMT2) acquired the ability to bind and methylate tRNAs 96 . The discovery of a eukaryotic DNA methyltransferase with a predominant tRNA methylation activity and only a modest DNA methylation activity showcases how evolution can modify protein surfaces to create new functions of DRBPs.
The ancient CSD DRBPs. The CSD is one of the most ancient nucleic acid-binding domains found in bacteria, archaea and eukaryotes. All CSD-containing proteins bind DNA and RNA (see Supplementary information S1 (table) ). In humans, there are several CSD-containing proteins, such as the three Y box-binding proteins, LIN28A and LIN28B (which are homologues of the Caenorhabditis elegans LIN-28), and CSD-containing protein E1 (CSDE1). Y box 1 (YB1; also known as YBX1) was originally named for its ability to bind and repress the Y box of major histocompatibility complex class II promoters 97 . YB1 also binds RNA, with roles in alternative splicing 98 , translational control 99 and RNA stabilization 100 . In addition, YB1 binds to damaged DNA and is involved in the DNA-damage response [101] [102] [103] -it translocates to the nucleus following stresses, such as exposure to ultraviole t radiation 104, 105 . In bacteria, CSDs exist in short proteins that contain one CSD with short flanking sequences. In Escherichia coli, there are nine such proteins (cold-shock protein A (CspA)-CspI), which are probably products of multiple gene duplication events 106 . Of these, CspA, CspB, CspG and CspI are induced by cold stress, with CspA constituting >10% of all protein synthesized during cold shock [107] [108] [109] [110] . Simultaneous deletion of these four genes results in lack of E. coli colony formation at temperatures at or lower than 25 °C (REF. 111 ). CspD is induced by nutrient stress 112 , but CspC and CspE are constitutively expressed at normal growth temperature 113 . Many (if not all) of the Csp proteins bind DNA and RNA 114, 115 and have similar roles to those of the human CSD-containing proteins, including in maintaining RNA stability 114 , in translational regulation 116 , in transcriptional control 116, 117 , in DNA replicatio n and repair 118, 119 , and in chromosome folding 120 . CSD-containing proteins are widespread in plants 121 , in which they have similar cellular functions. The first Csp-like protein found in plants was wheat CSP 1 (WCSP1), which is upregulated specifically by cold stress and binds ssDNA, dsDNA and RNA homopolymers 122 . WCSP1 was found to complement the cold-sensitive phenotype of the E. coli four-gene knockouts mentioned above 123 , exhibiting remarkable functional conservation. In addition, WCSP1 showed nucleic acid melting activity in E. coli, which is critical to preventing inappropriate nucleic acid secondary structures that disrupt and terminate transcription. This activity is similar to the endogenous E. coli CspA, which also has transcription antitermination activity 123 . Arabidopsis thaliana has four CSD-containing proteins, CSP1-CSP4, all of which can also complement the quadruple csp knockout in E. coli to varying degrees, suggesting that their DNA and RNA interactions are well conserved during evolution [124] [125] [126] . Nature Reviews | Molecular Cell Biology Unlike their counterparts in bacteria, most plant and animal CSD-containing proteins have additional functional domains (including more CSDs), which expand their functions, protein-protein interactions and/or nucleic acid-binding specificities. For example, the human protein CSDE1 has five CSDs, which increase the protein's affinity for target RNA sequences 127 . YB1 has both an N-terminal and a C-terminal domain flanking its CSD, which can support homomultimerization and interactions with many other protein partners (reviewed in REF. 128 ). In addition to its CSD, WCSP1 has three CCHC zinc-fingers, through which most of its dsDNA binding is mediated 122 . Nevertheless, the exceptional sequence and functional conservation between eukaryotic CSD-containing proteins and bacterial Csp proteins demonstrate a conserved, ancient role and origin of the domain. It is likely that a CSD fold that was capable of binding DNA and RNA was present in the last common ancestor of bacteria, archaea and eukaryotes 129 .
The curious case of DNMT2. DNA methylation has important roles in gene expression and repression of transposable elements in eukaryotic cells. There are three eukaryotic proteins in the cytosine-C5 DNA methyltransferase family: DNMT1, DNMT2 and DNMT3. Whereas DNMT1 and DNMT3 play important parts in maintaining genome-wide methylation, DNMT2 has little DNA methylation activity 130 and is instead capable of methylating tRNAs 96 (FIG. 5a) . When this activity was discovered, it was speculated that the three eukaryotic DNMTs might have evolved from an RNA methyltransferase 96 . However, there is no evidence that DNMT2 is more closely related to the ancestral protein of the family members. In fact, the three eukaryotic DNMTs may not be monophyletic and may have evolved from separate bacterial DNA methylation restriction-modification enzymes 131 . Thus, it seems likely that DNMT2 shifted its nucleic acid specificity from DNA to RNA in the last common eukaryotic ancestor 131 (FIG. 5b) .
Despite the relatively narrow substrate specificity of DNMT2 compared with that of its family members, it is highly conserved and is the only extant DNMT in some species, such as Schizosaccharomyces pombe and Drosophila melanogaster 131 . This seems to indicate that DNMT2 has an important physiological role; however, Dnmt2 −/− mice are viable and fertile, and yield no obvious phenotype 96 . This apparent contradiction was resolved with the recent report that deletion of DNMT2 in addition to another tRNA methyltransferase, NSUN2, in mice is lethal 132 . These mice show defects in tRNA stability, protein synthesis and differentiation 132 , implying that the DNA methylation activity of DNMT2 is dispensable, whereas its tRNA methylation activity is not.
NSUN2 is a member of the nuclear protein 1 (NCL1) family of eukaryotic RNA cytosine-C5 methyltransferases, which are broadly distributed among eukaryotes 133 . Interestingly, NSUN2 itself is a DRBP and is able to bind and methylate both tRNA and hemi-methylated DNA 134 . Crosslinking immunoprecipitation-based analyses showed that NSUN2 also methylates mRNAs and non-coding RNAs 135 . Given the distant evolutionary relationship between DNA and RNA cytosine-C5 methyltransferases 131 , NSUN2 and DNMT2 have most likely undergone convergent evolution from an RNAbinding and a DNA-binding protein family, respectively, to ensure proper tRNA modification. These evolutionary trajectories have bestowed on both proteins the ability (if residual) to bind and modify both DNA and RNA. This indicates not only that proteins with evolutionarily conserved DNA-binding activities are capable of binding RNA (and vice versa) but also that some nucleic acid substrates may be similar enough in sequence and structure to promote binding promiscuity. As mentioned above, this phenomenon is exploited by RNAs, both endogenous and artificial, that function as decoys to modulate DRBP function 1, 19, 136 .
Conclusion and perspectives
In this Analysis, we have demonstrated that DRBPs constitute a significant fraction of cellular proteins -perhaps 2% of the human proteome -and have important . DNA (cytosine-5)-methyltransferase 1 (DMNT1) and DMNT3 play a part in initiating and maintaining DNA methylation, whereas DNMT2 methylates tRNAs. This modification is critical for maintaining tRNA stability and cell viability. b | The evolution of the three major DNMTs 131 is depicted in a cladogram. DNMT2 probably diverged from its ancestral DNA methyltransferase to perform a critical role in methylating tRNAs, a function which it performs redundantly with NSUN2 (REF. 132 ). This radical change in substrate specificity highlights the ability of evolution to reshape a DNA-binding interface into one that preferentially recognizes RNA.
Intrinsically disordered protein
A protein that does not have a well-ordered three-dimensional structure, such as proteins containing random coils or multiple domains connected with flexible linkers. Systematic evolution of ligands by exponential enrichment (SELEX) . A technique to identify ligand-bindingsequence specificity that is based on sequential rounds of binding of an oligonucleotide library to the ligand, followed by PCR amplification of the bound sequences. cellular roles. Their functions include the control of transcription and translation, DNA repair, mediating responses to stress, splicing and apoptosis. These functions are intimately linked to the structures of DRBPs: orthogonal binding of DNA and RNA provides an opportunity for competitive regulation of transcription by decoy RNAs, whereas simultaneous binding of DNA and RNA permits transcriptional activation by RNA coactivators or allows the recruitment of RNA-containing complexes to specific DNA loci. In turn, the structures underlying DRBP functions are linked to their evolution. Some DRBPs contain ancient domains that have long bound DNA or RNA; others contain multiple domains that separately confer DNA-and RNA-binding abilities and mediate their functional roles.
The majority of RNA-binding proteins have had remarkably similar motifs during evolution 137 , although individual members of protein families, such as the forkhead box transcription factors, can have diverse nucleic acid sequence specificities arising from independent evolutionary events 138 . It is also worth noting that intrinsically disordered protein domains that do not fold into defined secondary structures may also play important parts in mediating nucleic acid binding 14 , as was found for RNA chaperones 139 . In addition to protein evolution, nucleic acid sequence evolution has important roles in the development of DRBP function. The discovery of lncRNAs illuminated new cellular binding targets for proteins that were previously thought of as DNA-specific binding proteins. Tens of thousands of human lncRNAs have been catalogued 140 , and it is likely that many of them have yetundiscovered functions requiring binding to proteins that are currently considered as DNA-specific binding proteins or that have so far only been shown to bind RNA in vitro. For example, the GCR and the oestrogen receptor were shown to bind DNA and RNA competitively >20 years before a physiological role for RNA-steroid receptor interactions was established [141] [142] [143] . Experimental selection techniques, such as systematic evolution of ligands by exponential enrichment (SELEX), have been used to develop inhibitory RNA aptamers for DNA-binding proteins, such as NF-κB. If such inhibitory RNA binding is functionally advantageous, the rapidly evolving sequences of l ncRNAs 144 could provide a platform for the evolution of an analogous endogenous function, and many DRBPs may have species-specific RNA targets. For example, the RNA Lethe, which binds NF-κB, exists only in mice and is not present even in the closely related rat genome 145 .
Proteins that bind both DNA and RNA could have several obvious functional advantages. By binding to both mRNAs and their encoding promoters, DRBPs can exert a powerful, amplified effect on gene expression. This also allows greater flexibility in generating cellular responses, as these DRBPs could both produce rapid effects on protein synthesis and impart long-acting changes on gene expression. At a cellular level, using one DRBP rather than two independent DNA-binding and RNA-binding proteins is more efficient, as it requires the transcription and translation of only one gene product. Finally, competitive RNA and DNA binding by some DRBPs allows an additional level of transcription factor regulation through decoy RNAs. These functional advantages, in addition to the rapid pace at which lncRNAs and their functions are being discovered, strongly indicate that more DRBPs and DRBP-mediated functions will be discovered in the coming years.
